Protected: C&L Video

by Kerentech|Published December 17, 2020

This content is password protected. To view it please enter your password below:

Password:

Cell and Life Therapeutics announces that Prof.Ankur Jain in MIT Biology Dept., joins the Company as CSO and the opening of its US company.

Cell and Life Therapeutics is developing next-generation small-molecule medicines to target the RNA cycle for treating neurodegenerative and oncology disorders. In collaboration […]

Published October 27, 2022

EmstoPA has received the Regulatory Endorsement of Development Program by British MHRA

We are proud to announce that our client EmstoPA has received the Regulatory Endorsement of Development Program by British MHRA and US FDA: The […]

Published October 13, 2022

Our client BrainEver Receives FDA Orphan Drug Designation for BREN-02, (human recombinant Engrailed 1) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

BREN-02 is expected to be administered in clinical trials in ALS patients in the second half of 2021, subject to preclinical toxicity […]

Published May 22, 2019

Our client Goodgut signs an agreement with Palex to launch first non-invasive diagnostic tests for IBS and IBD

GoodGut has signed an agreement with Palex Medical to start selling its new non-invasive diagnostic tests RAID-Dx for irritable bowel syndrome (IBS) […]

Previous post Our client Goodgut signs an agreement with Palex to launch first non-invasive diagnostic tests for IBS and IBD
Back to post list
Next post Our client BrainEver Receives FDA Orphan Drug Designation for BREN-02, (human recombinant Engrailed 1) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)